Holly Buckley

I mean, I don't think that the non-compete effort is going to be back at the federal level. I think that'll stay with the states. It's my personal belief. I just don't think that it's going to come back at the federal level. And I think that Notwithstanding that, I think there's been a permanent shift of kind of anti-non-compete.

It was already the trend, but I think with the federal effort, it's further kind of weakened non-competes. And I think they will continue to be eroded at the state level, especially for lower income, but also just in general, the employment-based non-compete, I think, will continue to be eroded. I think in terms of AI, we've heard some initial statements from

It was already the trend, but I think with the federal effort, it's further kind of weakened non-competes. And I think they will continue to be eroded at the state level, especially for lower income, but also just in general, the employment-based non-compete, I think, will continue to be eroded. I think in terms of AI, we've heard some initial statements from

on the federal level, on the Republican side, that there's going to be less regulation of AI than there would have been under the Biden administration, where I think there was certainly going to be a much stronger effort to have federal regulation. And it was you know, under the guise of national security. But I think there was a much stronger fear of AI on the Democrat side.

on the federal level, on the Republican side, that there's going to be less regulation of AI than there would have been under the Biden administration, where I think there was certainly going to be a much stronger effort to have federal regulation. And it was you know, under the guise of national security. But I think there was a much stronger fear of AI on the Democrat side.

And I think on the Republican side, I think we'll see less regulation there. I think on merger and acquisitions, I think we're going to see a move away from the much tougher regulation of M&A. And I think part of the sell for the business community on a Trump administration is the kind of more pro-business, pro-M&A climate that's been promised here.

And I think on the Republican side, I think we'll see less regulation there. I think on merger and acquisitions, I think we're going to see a move away from the much tougher regulation of M&A. And I think part of the sell for the business community on a Trump administration is the kind of more pro-business, pro-M&A climate that's been promised here.

So I do think we're going to see a rolling back of Lena Khan's agenda on many fronts. I'm probably most curious on the big tech front, just given the initial statements from Andrew Ferguson or not statements, but the source is reporting that Andrew Ferguson was still going to continue the scrutiny on big tech, but such a strong big tech presence in the Trump orbit.

So I do think we're going to see a rolling back of Lena Khan's agenda on many fronts. I'm probably most curious on the big tech front, just given the initial statements from Andrew Ferguson or not statements, but the source is reporting that Andrew Ferguson was still going to continue the scrutiny on big tech, but such a strong big tech presence in the Trump orbit.

I'm very curious to see what happens there.

I'm very curious to see what happens there.

Thanks for letting me do that. Next week, we're going to be in Dallas for a healthcare private equity pop-up event on January 29th. Chris Kersey from Havencrest Capital, who's just a fascinating guy, is going to be talking with Tim Fry, my partner, about deal trends and macroeconomic trends for 2025. We still have some space left there. We've got 60 plus folks who are going to be joining us.

Thanks for letting me do that. Next week, we're going to be in Dallas for a healthcare private equity pop-up event on January 29th. Chris Kersey from Havencrest Capital, who's just a fascinating guy, is going to be talking with Tim Fry, my partner, about deal trends and macroeconomic trends for 2025. We still have some space left there. We've got 60 plus folks who are going to be joining us.

The goal of these events is to do a little bit of content, a little bit of discussion, but then really just a heavy focus networking event. And that's in the evening on January 29th next week. We still have some space left. You're welcome to reach out to me on LinkedIn. or email me at hbuckley at mcguirewoods.com if you'd like to attend and I'll get you the registration information.

The goal of these events is to do a little bit of content, a little bit of discussion, but then really just a heavy focus networking event. And that's in the evening on January 29th next week. We still have some space left. You're welcome to reach out to me on LinkedIn. or email me at hbuckley at mcguirewoods.com if you'd like to attend and I'll get you the registration information.

And then on May 14th and 15th in Chicago, we have our annual healthcare private equity meeting at the Ritz. We're really excited for the agenda. We've really broadened out the agenda this year to have a much heavier focus on pharma services, healthcare tech, as well as our traditional focus on provider services. and kind of deal trends. And so it's going to be a great agenda.

And then on May 14th and 15th in Chicago, we have our annual healthcare private equity meeting at the Ritz. We're really excited for the agenda. We've really broadened out the agenda this year to have a much heavier focus on pharma services, healthcare tech, as well as our traditional focus on provider services. and kind of deal trends. And so it's going to be a great agenda.

I would love to see your registrations open again. You can email me or just go straight to the registration page on the McGuire Woods website. But it's going to be, I think, our best ever event. So definitely reach out if I can answer any questions.

I would love to see your registrations open again. You can email me or just go straight to the registration page on the McGuire Woods website. But it's going to be, I think, our best ever event. So definitely reach out if I can answer any questions.

He was also the former chairman of the board of Johns Hopkins Medicine. So just very accomplished guy. And we were thrilled to get him as a speaker and someone to share thoughts on what's going on. He's a very plugged in, very smart guy. So super excited about that.